InvestmentApr 28, 2026, 08:36 AM
CLYM Announces $110.0M Private Placement of Securities
AI Summary
Climb Bio, Inc. announced it has entered into a securities purchase agreement for a private placement, expecting to raise approximately $110.0 million in gross proceeds. The offering includes the sale of 9,481,000 shares of common stock at $9.50 per share and 2,106,000 pre-funded warrants at $9.4999 per warrant, with an exercise price of $0.0001 per share. The private placement saw participation from new and existing institutional accredited investors, including Adage Capital Partners, L.P. and RA Capital Management, and is expected to close around April 29, 2026.
Key Highlights
- Climb Bio, Inc. announced a private placement for aggregate gross proceeds of approximately $110.0 million.
- The company is selling 9,481,000 shares of common stock at $9.50 per share.
- Additionally, 2,106,000 pre-funded warrants are being sold at $9.4999 per warrant.
- Each pre-funded warrant has an exercise price of $0.0001 per share.
- The private placement included participation from new and existing shareholders including Adage Capital Partners, L.P., RA Capital Management, and others.
- The closing is expected on or about April 29, 2026.
- The Company will file a resale registration statement within 45 days of closing.
Price Impact
More from CLYM